Transgene Biotek Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

75.77

75.77

75.77

75.77

75.77

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-81.98

-75.97

-71.11

-60.67

-49.71

Loan funds

Secured loans

4.95

4.77

4.39

4.13

3.95

Unsecured loans

8.17

7.25

6.94

6.20

5.19

Total

6.91

11.82

15.99

25.42

35.19

Uses of funds

Fixed assets

Gross block

19.21

24.07

33.81

43.49

53.19

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

12.76

12.67

12.49

12.28

12.09

Net block

6.45

11.40

21.32

31.20

41.10

Capital work-in-progress

1.87

1.87

1.87

1.87

1.87

Investments

0.11

0.11

0.01

-

-

Net current assets

Current assets, loans & advances

24.06

23.85

23.79

23.79

23.69

Less : current liabilities & provisions

25.56

25.40

31.00

31.44

31.47

Total net current assets

-1.51

-1.55

-7.21

-7.65

-7.78

Miscellaneous expenses not written

-

-

-

-

-

Total

6.91

11.82

15.99

25.42

35.19

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.99

0.99

0.99

0.99

1.07

Number of equity sharesoutstanding (Lacs)

757.70

757.70

757.70

757.70

757.70